SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin (LTC) is currently trending, fueled by reports highlighting its "digital silver" status and recent outperformance, alongside discussions of an upcoming EzFill integration. The community expresses mixed sentiment, with some frustrated by its price action while many uphold strong long-term bullish convictions for its foundational role. Ongoing anticipation for Grayscale's potential ETF and future growth further drives conversation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is surging due to recent FDA updates, including priority review acceptance for AXS-05 for Alzheimer's disease agitation and positive pre-NDA meeting minutes supporting an AXS-12 submission for narcolepsy. The community is celebrating these significant advancements, seeing them as key catalysts driving the company toward profitability and anticipating further growth in its CNS portfolio.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the extension of China's NEV trade-in subsidies into 2026 fuels optimism across the sector, coinciding with an upbeat Q4 sales forecast from management suggesting potential profitability. While bulls are aggressively buying recent dips and anticipating a strong year-end, skeptics remain wary of past volatility and alleged market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Worried About an AI Bubble? Look to Surging International Stocks

We spotlight three international ETFs that are outperforming the S&P 500 by a wide margin.

<ul class="summary-bullets"><li>The U.S. president has wrapped up his state visit to Japan before heading to South Korea.</li><li>The US-Japan trade deal, clinched in September, provided for Japan investing $550 billion in the U.S. in return for a reduced tariff rate of 15%.</li><li>&nbsp;Toyota’s U.S. sales climbed 14%, outpacing the global sales growth of 3%.&nbsp;</li></ul>A Toyota Motor Corp. (TM) executive reportedly denied President Donald Trump’s claims that the Japanese automaker had committed to investing $10 billion in the United States.The U.S. president has wrapped up his state visit to Japan before heading to South Korea to attend the Asia-Pacific Economic Cooperation (APEC) summit, where he is expected to meet with his Chinese counterpart, Xi Jinping.U.S.-listed&nbsp;<a href="https://stocktwits.com/symbol/TM">Toyota shares</a> have gained about 11% so far this year.<h2 class="st-heading-2">Toyota’s Rebuttal&nbsp;</h2>Speaking on the sidelines of the Japan Mobility Show in Tokyo, Toyota executive Hiroyuki Ueda said no explicit promise of an investment of that size was made, Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/autos-transportation/toyota-says-it-did-not-explicitly-promise-trump-new-10-billion-investment-us-2025-10-29/">reported.</a> The U.S. is the company's single largest market, accounting for roughly 25%-30% of total sales.According to a Wall Street Journal <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/economy/trade/japan-u-s-outline-investment-plan-trump-says-toyota-to-invest-10-billion-in-u-s-auto-plants-dcf3d8a2">report,</a> Trump on Tuesday told U.S. military personnel stationed in Japan to “Go out and buy a Toyota.” The president reportedly said Japanese Prime Minister Sanae Takaichi informed him of Toyota’s $10 billion investment plan.&nbsp;The $10 billion outlay, however, was not part of up to $400 billion worth of investment projects announced by Japan’s Ministry of Finance this week. These investments are earmarked for sectors such as energy, artificial intelligence (AI), and critical minerals.The&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-us-clinched-largest-trade-deal-with-japan-nikkei-soars/ch8weNoR5tq">trade deal</a> struck between Japan and the U.S. in September provided for Japan investing $550 billion in the U.S. in return for a stepped-down tariff rate of 15%.<h2 class="st-heading-2">What’s At Stake For Toyota</h2>Earlier this week, Toyota reported that its September sales and production increased in the U.S. The automaker’s U.S. output jumped 29%, thanks to strong demand for its hybrids and a recovery from the suspension of production of two models a year earlier.&nbsp; Toyota’s U.S. sales climbed 14%, outpacing the global sales growth of 3%.&nbsp;In August, Toyota reduced its full-year operating income forecast by 16%, citing cost escalation stemming from U.S. tariffs on inputs. The company quantified the tariff impact as $10 billion.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/teradyne-stock-soars-after-hours-as-ai-demand-spurs-q3-beat/cLGZ7WzR3v0">Teradyne Stock Soars After-hours As AI Demand Spurs Q3 Beat, CFO To Step Down</a>

Raindrops are seen on Toyota car logo in Krakow, Poland on December 23, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Toyota Pushes Back On Trump’s Claims: No ‘Explicit’ Promise Was Made About $10B US Investment 

The US-Japan trade deal, clinched in September, provided for Japan investing $550 billion in the U.S. in return for a reduced tariff rate of 15%.

Equity

<ul class="summary-bullets"><li>Baird’s Tristan Gerra also added a “Fresh Pick” designation to the stock, reasoning that the valuation is attractive.</li><li>The analyst sees the company benefiting from easier revenue and gross margin comparisons throughout 2026.</li><li>STM stock has gained just 2% year-to-date (YTD), underperforming the broader market, the tech sector, and the semiconductor industry.</li></ul>Shares of Netherlands-based chipmaker STMicroelectronics N.V. (STM) were among the top five trending equity tickers on Stocktwits early Friday as retail investors warmed to the stock following Thursday’s earnings-induced slump&nbsp;of over 13%.Traders, however, remained cautious as the<a href="https://stocktwits.com/symbol/STM"> STMicroelectronics stock</a> was marginally higher in the early premarket session on Friday. An analyst, however, issued an upbeat commentary regarding the stock, stating that the worst may be behind.<h2 class="st-heading-2">Baird Designates STM Among Fresh Picks</h2>In a note released late Thursday, Baird analyst Tristan Gerra reiterated an ‘Outperform’ rating on STM stock but reduced the price target to $45 from $50. “At current levels, stock embeds all the grief regarding the 1Q GM reset, positioning investors well for an ongoing revenue and gross margin recovery each following quarter throughout 2026,” the analyst said.Gerra also added a “Fresh Pick” designation to the stock, reasoning that the valuation is attractive, as the stock trades at a five-year trough price-earnings (P/E)&nbsp;ratio of 8x. The analyst sees the company benefiting from easier revenue and gross margin comparisons throughout 2026.Thursday’s stock plunge came despite the company’s third-quarter double-beat, as investors fretted about its gross margin, which was below its long-term targets. The company also issued a sub-par full-year revenue outlook.<h2 class="st-heading-2">What Is Retail Feeling About STM Stock?</h2>Stocktwits users turned ‘extremely bullish’ on STM stock early Friday, improving from the ‘neutral’ sentiment seen a day ago. The message volume also surged to ‘extremely high’ levels.A bullish user states that the positive fourth-quarter outlook is ‘huge’ for the stock.<stembedurl>https://stocktwits.com/SmallCapAlert/message/633540803</stembedurl>Another user included the stock in their watchlist for Friday. “Very strong European chip company, outstanding numbers, strong revenue, and strong profit, but the share price crashed by 13%,” they said.<stembedurl>https://stocktwits.com/SmallCapAlert/message/633478031</stembedurl>STM stock has gained just 2% year-to-date (YTD), underperforming the broader market, the tech sector, and the semiconductor industry.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/super-micro-stock-rises-premarket-as-analyst-points-to-strong-orders/cLGJ0DLR3sh">Super Micro Stock Rises Premarket As Analyst Points To Strong Orders: Retail Traders Look To Capitalize On Thursday Dip</a>

The booth of the company STMicroelectronics markets electronic chips at the tech festival in Grenoble, France, on February 6, 2025. (Photo by Romain Doucelin/NurPhoto via Getty Images)

STM Stock Edges Higher Premarket After Post-Earnings Plunge: Analyst Touts Attractive Valuation, Retail Turns Uber-Bullish

Baird’s Tristan Gerra also added a “Fresh Pick” designation to the stock, reasoning that the valuation is attractive.

Jim Cramer reportedly cited ASML Holding N.V. (ASML) as a model for understanding the escalating trade war between the U.S. and China.&nbsp;According to a CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/15/cramer-this-european-company-is-key-to-understanding-us-china-trade-tensions.html">report</a>, Cramer advised investors seeking to understand trade tensions to consider the Dutch manufacturer of advanced lithography systems, which are essential for chip production.&nbsp;The company reported stronger-than-expected third-quarter (Q3) results, with&nbsp;revenue climbing 0.7% year-over-year (YoY) to&nbsp;€7.526 billion ($8.8 billion).&nbsp;However, the company also warned of a sharp decline in Chinese sales in 2026 due to tightening export restrictions. The U.S. has already imposed limits on advanced chip exports over national security concerns, and the Dutch government has introduced licensing requirements impacting ASML’s ability to sell its most sophisticated extreme ultraviolet (EUV) lithography machines to China, the report stated.&nbsp;ASML stock traded over 1% higher on Wednesday afternoon. On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume shifted to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:935/108;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_15_140644_png_ac18308c06.webp" alt="ASML’s Sentiment Meter and Message Volume as of 01:30 p.m. ET on Oct. 15, 2025 | Source: Stocktwits" width="935" height="108"><figcaption>ASML’s Sentiment Meter and Message Volume as of 01:30 p.m. ET on Oct. 15, 2025 | Source: Stocktwits</figcaption></figure>ASML continues to sell less advanced lithography tools to China. “That is the crux of what the Chinese are most worried about,” Cramer said. “Without&nbsp;ASML, they can’t do what Nvidia does.&nbsp;ASML is the key. And as long as we continue to put a restriction on ASML, the Chinese have to be going nuts, because they can’t beat,” the U.S. in chip technology,&nbsp;he added.Following its Q3 earnings, ASML also received a boost from BofA, which raised its price target on the company to&nbsp;€986 from&nbsp;€941 and reaffirmed a ‘Buy’ rating, according to TheFly.&nbsp;ASML stock has gained over 37% in the last 12 months.&nbsp;Exchange Rate:&nbsp;€1=$1.16Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/f5-stock-slides-4-percent-after-confirmation-of-cyberattact-by-a-nationa-state-actor/ch6FczhR3NU">F5 Stock Slides 4% After Confirmation Of Cyberattack By A Nation-State Actor</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Jim Cramer Reportedly Highlights ASML’s Central Role In US-China Chip Battle

According to a CNBC report, Cramer advised investors seeking to understand trade tensions to consider the Dutch manufacturer of advanced lithography systems, which are essential for chip production.

Shares of Dutch semiconductor-equipment maker ASML Holding N.V. (ASML)&nbsp;rose over 3.5% in the early premarket session on Wednesday following the company’s quarterly results.Veldhoven, Netherlands-based ASML said third-quarter revenue climbed 0.7% year-over-year (YoY) to 7.526 billion euros ($8.8 billion)&nbsp;even as it&nbsp;declined 2.3%&nbsp;from the prior quarter. The company sold 66 new lithography systems, a decrease from the 67 units sold in the second quarter.&nbsp;Lithography systems aid in creating intricate circuitry for microchips by using light to transfer patterns onto a silicon wafer. ASML supplies these systems to foundries such as Taiwan’s TSMC, which in turn makes chips for the world’s biggest tech companies, such as Apple, Nvidia, and Intel.&nbsp;Net bookings, which refer to customer orders, minus any cancellations and other adjustments, were at 5.4 billion euros, down from 5.54 billion euros in the previous quarter, but up sharply from the year-ago’s 2.63 billion euros.Extreme ultraviolet (EUV) lithography systems used in the production of the most advanced microchips utilized in high-performance computing, such as artificial intelligence (AI), accounted for 3.6 billion euros of the total net bookings.&nbsp;CEO Christophe Fouquet said, “Our third-quarter total net sales of €7.5 billion and gross margin of 51.6% were in line with our guidance, reflecting a good quarter for ASML.” He, however, warned that ASML’s total net sales in China in 2026 would decline significantly compared to&nbsp;outstanding business there in 2024 and 2025.ASML guided fourth-quarter net sales of 9.2 billion euros to 9.8 billion euros, with a gross margin of 51%-53%. The company expects full-year net sales growth of 15%, in line with the guidance issued in July, and raised its gross margin outlook to 53% from about 52%. It also does not expect 2026 sales to be lower than in 2025, while in mid-July, the company said it couldn’t confirm whether it would grow in the next fiscal year.On Stocktwits, <a href="https://stocktwits.com/symbol/ASML">ASML stock</a> was among the top 10 trending equity tickers as of early Wednesday. Retail sentiment toward the stock improved to ‘bullish’ (72/100) from ‘bearish’ the day before, and the message volume increased to ‘high’ levels.<figure class="image"><img style="aspect-ratio:618/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_15_at_4_12_59_AM_png_862249f112.webp" alt="Screenshot 2025-10-15 at 4.12.59 AM.png" width="618" height="53"><figcaption>ASML sentiment and message volume as of 4:10 a.m. ET, Oct. 14 | source: Stocktwits</figcaption></figure>The company said an interim dividend of 1.60 euros per ordinary share would be payable on Nov. 6.ASML stock has gained 43% year-to-date.Note: 1 euro = $1.16For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-s-and-p-500-futures-edge-higher-on-rate-cut-hopes/ch6nke0R3Zj">Nasdaq, S&amp;P 500 Futures Edge Higher On Rate-Cut Hopes: Traders Eye More Big Bank Earnings, Fed Talks</a>

ASML Stock Rises Premarket After Q3 Results: Margin Outlook Raised On AI Chip Boom

 CEO Christophe Fouquet warned of a significant decline in China revenue in 2026 but said the year’s sales will not decline year-over-year.

Swedish telecom company Home Telefonaktiebolaget LM Ericsson’s (ERIC) Nasdaq-listed ADRs are poised to open Tuesday’s session sharply higher, with the stock rising over&nbsp;12% in the early premarket session following the company’s quarterly results.<a href="https://stocktwits.com/symbol/ERIC">Ericsson’s ADR</a> has added merely 3.80% for the year-to-date period, underperforming the broader market, as represented by the S&amp;P 500 Index. On Stocktwits, retail sentiment toward the stock improved to ‘extremely bullish’ as of early Tuesday, and the message volume on the stream was at ‘high’ levels.<figure class="image"><img style="aspect-ratio:616/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_4_09_59_AM_png_abc0d3c0da.webp" alt="Screenshot 2025-10-14 at 4.09.59 AM.png" width="616" height="55"><figcaption>ERIC sentiment and message volume as of 4 a.m. ET, Oct. 14 | source: Stocktwits</figcaption></figure>The earnings report for the third quarter of the fiscal year 2025 showed adjusted earnings before interest, taxes, and amortization (EBITA) — called core earnings —of 15.8 billion Swedish Kronor ($1.67 billion). This marked a sharp rise from the year-ago’s 7.8 billion Kronor. The jump came after the company sold its call routing business iconective, which yielded a one-time capital gain of 7.6 billion Kronor. Adjusted EBITA margin improved to 28.1% from 12.6%.Net sales, however, slipped 4% year-over-year to 56.2 billion Kronor. On an organic basis, sales remained flat. CEO Börje Ekholm said, ”In Q3, we established margins at a new long-term level following strong operational execution over the past few years,” adding that Cloud Software and Services sales grew 9% on an adjusted basis, driven by strong growth in core networks.Looking ahead, Ericsson expects Enterprise organic sales to stabilize in the fourth quarter and the Radio Access Network (RAN) market to remain broadly stable. That said, it warned that increased uncertainty remained, both in terms of potential for further tariff changes as well as in the broader macroeconomic environment. The company hinted at increased shareholder distribution, citing solid recurring cash flow and a strong cash position at the end of the third quarter following the iconectiv sale.Separately, Ericsson announced a five-year strategic partnership to modernize Vodafone’s network footprint using Ericsson’s high-performing programmable network solutions across several key markets.($1 = 9.50 Swedish Kronor)For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-s-and-p-500-futures-slip-on-geopolitical-earnings-anxiety/ch6mL07R3lY">Nasdaq, S&amp;P 500 Futures Slip On Geopolitical, Earnings Anxiety: Strategist Says Trump’s China Threats Likely A Rare-Earths Deal Ploy</a>

Visitors at the Swedish telecom company Ericsson’s exhibition area during the India Mobile Congress 2025 at Yashobhoomi. 

Why Ericsson’s Stock Is Climbing Over 12% Premarket Today

Cloud Software and Services sales grew 9% on an adjusted basis, driven by strong growth in core networks.

JPMorgan initiated coverage of electric vertical take-off and landing aircraft manufacturer EHang (EH) with an ‘Overweight’ rating and $26 price target. The price target implies an upside of about 49% from the stock’s closing price on Thursday.The firm expects the global passenger electric vertical take-off and landing aircraft market to grow to $100 billion by 2040 and notes that EHang holds certificates in China that make it "uniquely positioned to scale from prototypes to a commercial model," as per TheFly. &nbsp;JPMorgan identifies EHang as China's "leading" eVTOL original equipment manufacturer and sees a clear path to breakeven ahead. On Stocktwits, retail sentiment around EHang rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels. Shares of the company jumped 4% in the pre-market session at the time of writing.<figure class="image"><img style="aspect-ratio:573/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_7_53_41_AM_png_f621c62fbe.webp" alt="EH's Sentiment Meter and Message Volume as of 7:53 a.m. ET on Aug. 22, 2025 | Source: Stocktwits" width="573" height="64"><figcaption>EH's Sentiment Meter and Message Volume as of 7:53 a.m. ET on Aug. 22, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that there is a lot to look forward to with the stock.<stembedurl>https://stocktwits.com/1billionclams/message/626173753</stembedurl>“EHang is positioned to capture an outsized share of early eVTOL volumes in China. Most peers remain 1-4 years behind in commercial readiness, while EHang is scaling toward 300-800 units annually in 2025-27E and building unmatched operator experience — laying the foundation for global leadership in the first wave of eVTOL adoption,” the firm stated, as <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/08/22/jpmorgan-sees-50percent-upside-ahead-for-chinas-leading-electric-vertical-aircraft-manufacturer.html">reported</a> by CNBC. “Multi-Product Portfolio aligned to monetize both near-term (sightseeing, public services) demand in China and long-term (cargo, intercity transport) demand globally.”JPMorgan remains optimistic on the long-term growth story for the stock, given the current order backlog of over 1000 units. The firm expects the company’s net profit to grow at a compound annual rate of 307% between fiscal years 2025 and 2027, CNBC reported.EH stock is up by 11% this year and by about 20% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dan-ives-ai-bubble-winners-and-losers/chsZRJORd0A">Dan Ives Reportedly Brushes Aside AI Bubble Concerns, Lists Down Winners And Losers: ‘You Cannot Get Too Nervous’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Global stock market chart and trading board - stock photo

JPMorgan Sees Near 50% Upside On This Chinese eVTOL Maker: Retail Believes There’s A Lot To Look Forward To

JPMorgan expects the global passenger electric vertical take-off and landing aircraft market to grow to $100 billion by 2040. 

JPMorgan expects the global passenger electric vertical take-off and landing aircraft market to grow to $100 billion by 2040 and noted that EHang holds certificates in China that make it "uniquely positioned to scale from prototypes to a commercial model," as per TheFly.

ETF Asset Report of the Month of July 

VOO led July ETF inflows with $12.68B, while LQD and IWM witnessed sharp outflows.

5 ETFs With Big Inflows Last Week on S&P 500's Record Rally

VOO, VXUS, GLD, SPY and DYNF led ETF inflows last week as the S&P 500 hit five straight record closes.


ETF Strategies to Follow in 2H 2025

Markets hit new record with bets on a "Goldilocks" economy, but volatility persists. AI and international ETFs like QQQ, IVES and EZU could be good bets for 2H. 

VXUS
Vanguard Total International Stock ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VXUS News

VXUSVanguard Total International Stock ETF